市場調査レポート
商品コード
1370424
整形外科軟部組織修復市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測Orthopedic Soft Tissue Repair Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
整形外科軟部組織修復市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測 |
出版日: 2023年10月15日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2~3営業日
|
整形外科軟部組織修復の世界市場規模は2022年に34億米ドルに達しました。今後、IMARC Groupは、2023年から2028年にかけて4.7%の成長率(CAGR)を示し、2028年までに46億米ドルに達すると予測しています。
整形外科軟部組織修復とは、損傷または損傷した組織を健康な組織に置き換えるプロセスを指します。神経、靭帯、血管、筋肉、腱、滑膜などで構成されます。整形外科的軟部組織の損傷は、スポーツや身体活動中に起こることが多いが、日常の単純な作業や特定の身体部位の継続的な使用によっても起こりうる。捻挫、挫傷、滑液包炎、挫傷、腱炎などは、腫れ、痛み、打撲、機能低下などを引き起こす一般的な軟部組織の損傷です。整形外科的軟部組織の修復は、開腹手術や関節鏡のような完全な低侵襲手術によって行うことができます。これらの処置は、痛みや腫れを軽減しながら可動性、筋力、組織の長さ、可動域を増加させ、治癒プロセスを促進します。
靭帯が弱くなり、骨格や神経筋系が変化する結果、怪我をしやすくなる老年人口が世界中で増加していることが、主に市場成長の原動力となっています。さらに、プロスポーツへの参加者の増加により、スポーツに関連した怪我のリスクが大幅に増加しており、これが整形外科的軟部組織修復手技の需要を促進しています。これとは別に、整形外科の靭帯断裂に起因する複雑な神経筋痛の管理に有効な多血小板血漿のような新しい治療法の導入が、市場成長に弾みをつけています。これに伴い、バイオプリンティング、生物学的メッシュ、バイオファブリケーションなどの新技術のイントロダクションが、市場の見通しをさらに明るいものにしています。その他の要因としては、広範な研究開発(R&D)活動、新しいデバイスや治療法の革新、1人当たりのヘルスケア支出の増加などが挙げられ、市場成長の原動力になると予想されます。
The global orthopedic soft tissue repair market size reached US$ 3.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.6 Billion by 2028, exhibiting a growth rate (CAGR) of 4.7% during 2023-2028.
Orthopedic soft tissue repair refers to the process of replacing the injured or damaged tissues with healthy tissues. It comprises nerves, ligaments, blood vessels, muscles, tendons and synovial membranes. Orthopedic soft tissue injuries often occur during sports and physical activities but can also be caused by simple everyday tasks and continuous use of a particular body part. Sprains, strains, bursitis, contusions, and tendinitis are some of the common soft tissue injuries that can result in swelling, pain, bruising and loss of function. The repair of orthopedic soft tissues can be performed through open surgical processes or by complete minimally invasive procedures such as arthroscopy. These procedures increase mobility, muscle strength, tissue length, and range of movement with reduced pain and swelling, thereby enhancing the healing process.
The rising geriatric population across the globe, which is more susceptible to injuries as a result of weakened ligaments and changes in skeletal and neuromuscular systems, is primarily driving the market growth. Additionally, the growing participation of individuals in professional sports has significantly increased the risks of sports-related injuries, which, in turn, is facilitating the demand for orthopedic soft tissue repair procedures. Apart from this, the introduction of new therapies, such as platelet-rich plasma, that are effective in managing complex neuromuscular pain caused due to orthopedic ligament tears are providing an impetus to the market growth. In line with this, the introduction of new technologies, including bioprinting, biological meshes, and biofabrication, is further creating a positive outlook for the market. Other factors, including extensive research and development (R&D) activities, innovations in new devices and therapies, and increasing healthcare per capita expenditure, are anticipated to drive the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global orthopedic soft tissue repair market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on procedure, injury location and end user.
Cruciate Ligaments Repair
Rotator Cuff Repair
Lateral Epicondylitis
Achilles Tendinosis Repair
Pelvic Organ Prolapse
Gluteal Tendon Repair
Hip Arthroscopy
Biceps Tenodesis
Others
Knee
Shoulder
Hip
Small Joints
Hospitals
Ambulatory Centers
Orthopedic Clinics
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Arthrex Inc., Becton Dickinson and Company, Boston Scientific Corporation, CONMED Corporation, Integra LifeSciences, Johnson & Johnson, LifeNet Health, MTF Biologics, Smith & Nephew plc, Stryker Corporation, Tissue Regenix Group plc and Zimmer Biomet.